NEUROTECH PHARMACEUTICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	6	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	12
SENATE	12

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	13

NEUROTECH PHARMACEUTICALS — Lobbying Disclosure | Poliscope